Weight changes and adverse pregnancy outcomes with dolutegravir- and tenofovir alafenamide fumarate-containing antiretroviral treatment regimens during pregnancy and postpartum

By sjmartinez • January 6, 2024

Hoffman RM, Brummel S, Ziemba L, Chinula L, McCarthy K, Fairlie L, Jean-Philippe P, Chakhtoura N, Johnston B, Krotje C, Nematadzira TG, Nakayiwa F, Ndyanabangi V, Hanley S, Theron G, Violari A, João E, Correa Junior MD, Hofer CB, Navanukroh O, Aurpibul L, Nevrekar N, Zash R, Shapiro R, Stringer JSA, Currier JS, Sax P, Lockman S; IMPAACT 2010/VESTED Study Team. Weight changes and adverse pregnancy outcomes with dolutegravir- and tenofovir alafenamide fumarate-containing antiretroviral treatment regimens during pregnancy and postpartum. Clin Infect Dis. 2024 Jan 5:ciae001. doi: 10.1093/cid/ciae001. Epub ahead of print. PMID: 38180851.

Tags: adverse pregnancy outcomes, antepartum weight change, HIV, Infectious Diseases, postpartum weight, Publications, Women’s health

Envisioning a Multidisciplinary HBV Cure Research Agenda

Dubé K, Ahmed A, Cohen C, Ibrahim Y, Yendewa GA, Cachay ER, Wang S, Marks K, Kim AY, Sugarman J, Thomas DL, Thio CL, Bhattacharya[...]

Estimation of prevention-effective CAB-LA concentrations among men who have sex with men (MSM) and transgender women (TGW) in HPTN 083

Hanscom B, Marzinke MA, Li X, Donnell D, Bies R, Hendrix CW, Wang Z, Acuipil C, Rinehart A, Collins JW, Rooney JF, Soto Torres L,[...]

Environmental and human health impact of contact precaution use for methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus in Los Angeles County

Lee PS, OYong K, Shah AN, Thiel C, LeBrun M, Miller LG, Rubin Z. Environmental and human health impact of contact precaution use for methicillin-resistant Staphylococcus[...]